Literature DB >> 6478419

Blood type A and familial breast cancer.

D E Anderson, C Haas.   

Abstract

The association between blood type A and breast cancer was evaluated in 648 patients with family histories of the disease, 1897 unselected patients, 4577 institutional blood donor controls, and 14,508 extramural blood donor controls. The familial patients were classified into three pedigree groups in which the lifetime breast cancer risks to first-degree relatives ranged from 11% to 32%. In the pedigree group associated with a relatively low risk to relatives, the authors saw a significant excess of blood type A individuals when compared with either control group. The unselected patient population, which was considered to refer to a general series of patients, also showed an excess of blood type A individuals with either control but a significant excess only in comparison with institutional controls. Patients from high-risk pedigrees with inherited forms of breast cancer showed no association when compared with either control group. The effect of blood type A on breast cancer risk was considered too small to be of use in identifying women at high risk. The results further suggested that the effect of blood type A on breast cancer development was capable of being masked by the effect of breast cancer susceptibility genes and/or that the inherited and noninherited types involve different etiologic mechanisms.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6478419     DOI: 10.1002/1097-0142(19841101)54:9<1845::aid-cncr2820540913>3.0.co;2-5

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  12 in total

1.  ABO blood group and breast cancer incidence and survival.

Authors:  Margaret A Gates; Mousheng Xu; Wendy Y Chen; Peter Kraft; Susan E Hankinson; Brian M Wolpin
Journal:  Int J Cancer       Date:  2012-02-10       Impact factor: 7.396

2.  Relative Risk of Various Head and Neck Cancers among Different Blood Groups: An Analytical Study.

Authors:  Khushboo Singh; Sunder Kote; Basavaraj Patthi; Ashish Singla; Shilpi Singh; Hansa Kundu; Swati Jain
Journal:  J Clin Diagn Res       Date:  2014-04-15

3.  ABO blood groups in relation to breast carcinoma incidence and associated prognostic factors in Moroccan women.

Authors:  S Zouine; F Marnissi; N Otmani; M Bennani Othmani; M El Wafi; K Kojok; Y Zaid; N Tahiri Jouti; N Habti
Journal:  Med Oncol       Date:  2016-05-30       Impact factor: 3.064

4.  A relationship between ABO blood groups and clinicopathologic characteristics of patients with gastric adenocarcinoma in China.

Authors:  Miao-Zhen Qiu; Dong-Sheng Zhang; Dan-Yun Ruan; Hui-Yan Luo; Zhi-Qiang Wang; Zhi-Wei Zhou; Feng-Hua Wang; Yu-Hong Li; Rui-Hua Xu
Journal:  Med Oncol       Date:  2010-11-04       Impact factor: 3.064

5.  Blood type, hormone receptor status, HER2/neu status, and survival in breast cancer: a retrospective study exploring relationships in a phenotypically well-defined cohort.

Authors:  Eiko Klimant; Ingrid Glurich; Bickol Mukesh; Adedayo A Onitilo
Journal:  Clin Med Res       Date:  2011-01-24

6.  Relationship between ABO blood groups and carcinoma of esophagus and cardia in Chaoshan inhabitants of China.

Authors:  M Su; S M Lu; D P Tian; H Zhao; X Y Li; D R Li; Z C Zheng
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

7.  Higher frequency of secretor phenotype in O blood group - its benefits in prevention and/or treatment of some diseases.

Authors:  Mohamad Salih Jaff
Journal:  Int J Nanomedicine       Date:  2010-11-02

8.  ABO blood type is associated with endometrial cancer risk in Chinese women.

Authors:  Wang-Hong Xu; Wei Zheng; Yong-Bing Xiang; Xiao-Ou Shu
Journal:  Chin J Cancer       Date:  2011-11

9.  Expression of alpha-GalNAc glycoproteins by breast cancers.

Authors:  S A Brooks; A J Leathem
Journal:  Br J Cancer       Date:  1995-05       Impact factor: 7.640

10.  Risk factors for anaplastic thyroid cancer.

Authors:  V Zivaljevic; N Slijepcevic; I Paunovic; A Diklic; N Kalezic; J Marinkovic; R Zivic; B Vekic; S Sipetic
Journal:  Int J Endocrinol       Date:  2014-05-18       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.